Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders-Reference-Cited by-同舟云学术

Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders

Published:2014-12-03 Issue:265 Volume:6 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Soden Sarah E.¹²³,Saunders Carol J.¹²³⁴,Willig Laurel K.¹²³,Farrow Emily G.¹²³⁴,Smith Laurie D.¹²³,Petrikin Josh E.¹²³,LePichon Jean-Baptiste¹²³,Miller Neil A.¹²,Thiffault Isabelle¹³⁴,Dinwiddie Darrell L.⁵⁶,Twist Greyson¹,Noll Aaron¹,Heese Bryce A.²³,Zellmer Lee¹⁴,Atherton Andrea M.¹²³,Abdelmoity Ahmed T.²³,Safina Nicole²³,Nyp Sarah S.²,Zuccarelli Britton²,Larson Ingrid A.¹²,Modrcin Ann²³,Herd Suzanne¹²,Creed Mitchell¹,Ye Zhaohui⁷,Yuan Xuan⁷,Brodsky Robert A.⁷,Kingsmore Stephen F.¹²³⁴

Affiliation:

1. Center for Pediatric Genomic Medicine, Children’s Mercy–Kansas City, Kansas City, MO 64108, USA.

2. Department of Pediatrics, Children’s Mercy–Kansas City, Kansas City, MO 64108, USA.

3. School of Medicine, University of Missouri–Kansas City, Kansas City, MO 64108, USA.

4. Department of Pathology, Children’s Mercy–Kansas City, Kansas City, MO 64108, USA.

5. Department of Pediatrics, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.

6. Clinical and Translational Science Center, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.

7. Department of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA.

Abstract

Molecular diagnosis of pediatric neurodevelopmental disorders by genomic sequencing is frequently informative and cost-effective and can affect clinical care.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference59 articles.

1. The utility of the traditional medical genetics diagnostic evaluation in the context of next-generation sequencing for undiagnosed genetic disorders

2. Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital Anomalies

3. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features

4. Application of array comparative genomic hybridization in 256 patients with developmental delay or intellectual disability

5. Array CGH analysis of a cohort of Russian patients with intellectual disability

Cited by 428 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An atypical form of 60S ribosomal subunit in Diamond-Blackfan anemia linked to RPL17 variants;JCI Insight;2024-08-01

2. MAGEL2 (patho‐)physiology and Schaaf–Yang syndrome;Developmental Medicine & Child Neurology;2024-07

3. D-Bifunctional Protein Deficiency Diagnosis—A Challenge in Low Resource Settings: Case Report and Review of the Literature;International Journal of Molecular Sciences;2024-04-30

4. Role of next generation sequencing in diagnosis and management of critically ill children with suspected monogenic disorder;European Journal of Human Genetics;2024-04-11

5. Real-world diagnostic outcomes and cost-effectiveness of genome-wide sequencing for developmental and seizure disorders: Evidence from Canada;Genetics in Medicine;2024-04